Journal of Inherited Metabolic Disease · 1999 · 43 citations · 6 references
MedicinePediatricsEarly DetectionMolecular ScreeningScreeningWilson DiseaseBlood-based ScreeningPediatric Wilson DiseasePilot Study DesignPilot Study PlanningPilot Study Sample Size
Wilson disease (WD) is an autosomal recessive disorder of copper accumulation leading to liver and/or brain damage. In this paper, we describe the results of a pilot study of screening for WD using ceruloplasmin determinations in dried blood samples. Specimens were collected from children aged 1 to 6 years who were seen at local paediatric outpatient clinics in the Miyagi Prefecture. We measured ceruloplasmin (CP) concentrations in 2789 children using an enzyme-linked immunosorbent assay. The mean value was 12.4 +/- 3.95 mg/dl blood. Among these children, we identified two (case 1, male, 2 years old; case 2, female, 3 years old) with markedly reduced CP concentrations. Apart from low serum copper concentrations, their biochemical findings were almost normal, as were growth and development. To confirm the diagnosis, we analysed the WD gene and detected A803T/2871delC mutations in case 1 and R778L/G1035V mutations in case 2. We conclude that these children were presymptomatic WD patients. The CP level in dried blood samples from children aged 1 to 6 years appears to be a reliable marker for early detection of WD.
6
The Wilson disease gene: spectrum of mutations and their consequences
Gordon R. Thomas, John Forbes, Eve A. Roberts et al. · Nature Genetics · 1995 · 571 citations
Konstantin Petrukhin, Svetiana Lutsenko, Barbara M. Ross et al. · Human Molecular Genetics · 1994 · 355 citations